Compare HXHX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HXHX | NVNO |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 16.7M |
| IPO Year | 2025 | N/A |
| Metric | HXHX | NVNO |
|---|---|---|
| Price | $0.45 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 355.7K | ★ 956.3K |
| Earning Date | 04-30-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $25,571,810.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.44 | $0.30 |
| 52 Week High | $6.29 | $5.62 |
| Indicator | HXHX | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 33.94 | 31.90 |
| Support Level | $0.45 | $0.32 |
| Resistance Level | $0.53 | $0.37 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 1.86 | 6.24 |
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.